Search research articles
Contact Us
Filters
Showing results (421-430 of 430) with videos related to
Page
of 43
Sort By:
You have reached the last page of results.
This site can display upto 430 results.
Environmental Science. Processes & Impacts
|
January 23, 2026
Per- and polyfluoroalkyl substances (PFAS) and other contaminants of concern in tribal waters of Montana
Kelly L Smalling, Paul M Bradley, Kristin M Romanok, et al.
Plos One
|
February 6, 2023
Profiles of COVID-19 vaccine hesitancy by race and ethnicity in eastern Pennsylvania
Kenya M Colvin, Kennedy S Camara, Latasha S Adams, et al.
Diabetes Care
|
March 31, 2025
Developing a Computable Phenotype for Identifying Children, Adolescents, and Young Adults With Diabetes Using Electronic Health Records in the DiCAYA Network
Hui Shao, Lorna E Thorpe, Shahidul Islam, et al.
Nature
|
September 3, 2025
Dynamic fibroblast-immune interactions shape recovery after brain injury
Nathan A Ewing-Crystal, Nicholas M Mroz, Amara Larpthaveesarp, et al.
JAMA Surgery
|
September 7, 2022
Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial
Marie Osdoit, Christina Yau, W Fraser Symmans, et al.
NPJ Breast Cancer
|
August 23, 2018
Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint
Judy C Boughey, Michael D Alvarado, Rachael B Lancaster, et al.
Annals of Surgical Oncology
|
June 28, 2023
Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial
Judy C Boughey, Hongmei Yu, Catherine Lu Dugan, et al.
NPJ Breast Cancer
|
January 25, 2019
Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint
Judy C Boughey, Michael D Alvarado, Rachael B Lancaster, et al.
Nature Communications
|
November 6, 2021
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2<sup>+</sup> breast cancer in the adaptively randomized I-SPY2 trial
Amy S Clark, Christina Yau, Denise M Wolf, et al.
Biological Psychiatry
|
August 25, 2019
Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling
Brett V Johnson, Raman Kumar, Sabrina Oishi, et al.
Page
of 43
Search research articles
Search
Showing results (421-430 of 430) with videos related to
Sort By:
Page
of 43
You have reached the last page of results.
This site can display upto 430 results.
Environmental Science. Processes & Impacts
|
January 23, 2026
Per- and polyfluoroalkyl substances (PFAS) and other contaminants of concern in tribal waters of Montana
Kelly L Smalling, Paul M Bradley, Kristin M Romanok, et al.
Plos One
|
February 6, 2023
Profiles of COVID-19 vaccine hesitancy by race and ethnicity in eastern Pennsylvania
Kenya M Colvin, Kennedy S Camara, Latasha S Adams, et al.
Diabetes Care
|
March 31, 2025
Developing a Computable Phenotype for Identifying Children, Adolescents, and Young Adults With Diabetes Using Electronic Health Records in the DiCAYA Network
Hui Shao, Lorna E Thorpe, Shahidul Islam, et al.
Nature
|
September 3, 2025
Dynamic fibroblast-immune interactions shape recovery after brain injury
Nathan A Ewing-Crystal, Nicholas M Mroz, Amara Larpthaveesarp, et al.
JAMA Surgery
|
September 7, 2022
Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial
Marie Osdoit, Christina Yau, W Fraser Symmans, et al.
NPJ Breast Cancer
|
August 23, 2018
Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint
Judy C Boughey, Michael D Alvarado, Rachael B Lancaster, et al.
Annals of Surgical Oncology
|
June 28, 2023
Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial
Judy C Boughey, Hongmei Yu, Catherine Lu Dugan, et al.
NPJ Breast Cancer
|
January 25, 2019
Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint
Judy C Boughey, Michael D Alvarado, Rachael B Lancaster, et al.
Nature Communications
|
November 6, 2021
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2<sup>+</sup> breast cancer in the adaptively randomized I-SPY2 trial
Amy S Clark, Christina Yau, Denise M Wolf, et al.
Biological Psychiatry
|
August 25, 2019
Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling
Brett V Johnson, Raman Kumar, Sabrina Oishi, et al.
Page
of 43